U.S. jury hits Bayer with $81 million in Roundup cancer trial

U.S. jury hits Bayer with $81 million in Roundup cancer trial

FILE PHOTO: Monsanto’s Roundup weedkiller atomizers are displayed for sale at a garden shop near Brussels, Belgium November 27, 2017. REUTERS/Yves Herman/File Photo

(Reuters) – A U.S. jury on Wednesday awarded $80.9 million to a man who claimed his use of Bayer AG’s glyphosate-based weed killer Roundup caused his cancer, in the latest legal setback for the company facing thousands of similar lawsuits.

The jury in San Francisco federal court said the company was liable for plaintiff Edwin Hardeman’s non-Hodgkin’s lymphoma.

Reporting by Alexandria Sage in San Francisco; editing by Bill Berkrot

Source link